Please try another search
For the three months ended 31 March 2022, VIVO Cannabis Inc revenues increased 26% to C$6.9M. Net loss increased 21% to C$4.3M. Revenues reflect Medical Cannabis segment increase of 27% to C$6.2M, Patient Clinics segment increase of 15% to C$704K. Higher net loss reflects Gain on other financial assets decrease from C$1.3M (income) to C$0K, Increase in fair value due to biological decrease of 28% to C$1.6M (income).
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 6.93 | 6.89 | 6.17 | 6.43 |
Gross Profit | 0.19 | -1.48 | 0.41 | 0.39 |
Operating Income | -4.7 | -78.19 | -2.92 | -5.92 |
Net Income | -4.3 | -59.51 | -1.11 | -5.48 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 112.56 | 118.41 | 196.79 | 199.35 |
Total Liabilities | 30.65 | 32.38 | 51.8 | 53.04 |
Total Equity | 81.91 | 86.03 | 144.99 | 146.31 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -3.63 | -9.59 | -7.89 | -4.82 |
Cash From Investing Activities | -0.16 | 8.28 | 7.79 | 7.86 |
Cash From Financing Activities | -0.04 | 7.02 | 7.05 | 7.08 |
Net Change in Cash | -3.76 | 5.6 | 6.67 | 10.01 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review